The [PEARL] Study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Everolimus (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms PEARL
- 06 Sep 2016 Planned primary completion date changed from 1 May 2016 to 1 Oct 2016.
- 06 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 18 Sep 2014 New trial record